Today: 9 June 2026
LVMH stock price: investors circle Feb. 3 after Moët Hennessy pay deal, strike call
31 January 2026
2 mins read

LVMH stock price: investors circle Feb. 3 after Moët Hennessy pay deal, strike call

Paris, January 31, 2026, 17:38 CET — The market has closed.

  • On Friday, LVMH shares ended at 546.90 euros, marking a 0.8% gain for the session.
  • Hennessy, part of Moët Hennessy, secured a pay agreement; champagne brands still brace for a strike set for Feb. 3.
  • A Bain report highlighted a fragile and uneven rebound in China’s luxury market for 2026.

LVMH Moet Hennessy Louis Vuitton SE shares ended Friday at 546.90 euros, rising 0.83% that day. Still, the stock has slipped 7.52% over the last five sessions and tumbled 15.21% year-to-date.

Monday’s session will see China back under the luxury spotlight. Bain & Company projects the country’s personal luxury goods market to notch modest growth in 2026, following a 3% to 5% dip in 2025. But the firm cautions the recovery won’t be smooth or broad-based; senior partner Bruno Lannes described the growth as “segment specific.” The report also highlights stronger trends in Greater China for Richemont this month. Reuters

LVMH remains a key gauge for investors watching the sector, especially after its recent earnings report rattled the market. Now, fresh labor news from its drinks division is introducing added uncertainty, just as the stock searches for stability.

Two sources told Reuters that management and unions at the Hennessy cognac unit have agreed on one-off payments to compensate workers for bonuses lost last year. The payouts will equal 6.8% of annual salary, with a minimum of around 3,200 euros per employee. This deal brings some relief to Moët Hennessy, overseen by Jean-Jacques Guiony and Alexandre Arnault, following rare strike action at the division. The cognac brand has faced pressure from U.S. tariffs, its largest sales market, Reuters reported.

Tensions are mounting at the champagne houses. The CGT union at Moët & Chandon and Veuve Clicquot announced a fresh strike for Feb. 3, following walkouts earlier this month and in December over year-end bonuses, a CGT press release said.

LVMH shares plunged as much as 8.2% on Jan. 28, following results that revealed a 3% drop in its fashion and leather goods division during the holiday quarter. The wine and spirits unit also slumped, with revenue down 9%, and the operating margin dipped to 22% in 2025 from 23.1% the previous year. CEO Bernard Arnault warned of “reason to be prudent” amid geopolitical tensions and economic uncertainty. Meanwhile, CFO Cécile Cabanis stressed the need for growth as the group doubled down on cost control. Barclays analyst Carole Madjo noted the tone “casts a shadow” over the luxury sector. The decline weighed on rivals like Kering and Hermès. Reuters

On Friday, Barclays maintained a neutral rating on the stock but lowered its target price to 570 euros from 580, according to a note reported by MarketScreener.

In its January shareholder letter, LVMH announced it plans to recommend a 13-euro dividend per share at the April 23 meeting. This includes a 7.50-euro final payout scheduled for April 30, following a 5.50-euro interim dividend paid last December.

Traders are currently weighing two key signals: if demand in China is strong enough to boost volumes, and if the drinks division can steer clear of further walkouts. Monday’s moves might depend more on headlines than fresh data.

The downside scenario is straightforward. Disruptions at Moët Hennessy would likely shift focus back to costs and margins. Plus, a patchy recovery in China would complicate efforts to push through price increases.

Tuesday, Feb. 3, is the key date: Hennessy’s pay agreement is set to be signed, while the CGT plans another strike at Moët & Chandon and Veuve Clicquot. Investors will be watching closely to see if the dispute spreads as the week kicks off.

Stock Market Today

  • Docebo (TSX:DCBO) Valuation Story Shifts Amid Revised Earnings Guidance
    June 9, 2026, 10:40 AM EDT. Docebo's fair value remains at CA$35.97 despite updated financial models, reflecting a recalibration of valuation assumptions. Analysts highlight contrasting bullish views, citing a clear growth story backed by recent revenue guidance raising full-year 2026 estimates to US$271-275 million, against bearish concerns over limited analyst coverage and potential risks. The e-learning software provider forecast revenue of approximately US$65.4-65.6 million for Q1 2026, and US$66.7-66.9 million for Q2. At its Inspire 2026 event, Docebo unveiled a next-generation learning platform and key product updates, signaling strategic progress. Investors should monitor shifting assumptions and sector context amid evolving market narratives.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
First U.S. bank failure of 2026: What happened after Metropolitan Capital Bank & Trust was shut
Previous Story

First U.S. bank failure of 2026: What happened after Metropolitan Capital Bank & Trust was shut

Gold price set for a bumpy week after historic slide from record highs
Next Story

Gold price set for a bumpy week after historic slide from record highs

Go toTop